MOL 0275

Drug Profile

MOL 0275

Alternative Names: MOL 027-5

Latest Information Update: 28 Nov 1997

Price : $50

At a glance

  • Originator Molecumetics
  • Class Antivirals
  • Mechanism of Action HIV envelope protein gp120 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV-1 infections

Most Recent Events

  • 28 Nov 1997 Discontinued-Preclinical for HIV-1 infections in USA (Unknown route)
  • 10 Oct 1995 Preclinical development for HIV-1 infections in USA (Unknown route)
  • 29 Sep 1995 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top